Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?Yan Wu(Jiangsu University), Yongchang Chen(Jiangsu University)Medical Science MonitorFebruary 5, 201810.12659/msm.906213Cited by 3SaveCiteExport RISWatch citationsRelated PapersCross-linked hyaluronic acid gel inhibits metastasis and growth of gastric and hepatic cancer cells:<i>in vitro</i>and<i>in vivo</i>studies|Oncotarget|2016|19PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells|Oncotarget|2016|18Nitric oxide/cyclic guanosine monophosphate inducers sodium nitroprusside and L-arginine inhibit the proliferation of gastric cancer cells via the activation of type II cyclic guanosine monophosphate-dependent protein kinase|Oncology Letters|2015|9